ABSTRACT
The present report describes the peptide commonality between JC virus (JCV) and the human proteome at the heptamer level. In total, 53 viral heptapeptides occur in functionally important human proteins with potential consequences for host functions and JCV pathogenesis. A paradigmatic example of a crucial peptide match is the SGKTTLA sequence, shared by JCV LT antigen and human nicotinamide/nicotinic acid riboside kinase, an enzyme involved in myelination processes. In general, the JCVversus-host heptapeptide overlap may result in a competition between viral sequences and identical motifs in host enzymic active sites, adhesive domains, regulatory signaling motifs, etc., thus interfering with essential reactions and posing disadvantages to the cell. Overall, this study provides a starting point for investigating the role of peptide commonality in hostpathogen interactions.
INTRODUCTION
Recent reports showed that an unexpected level of sequence percentage identity at the penta-, hexa-, and heptapeptide levels unifies viruses and Homo sapiens (1) (2) (3) (4) (5) . JCV is no exception to the rule of a widespread and ample distribution of viral peptide motifs through the human proteome, with more than 20 thousands occurrences in the human proteins at the pentapeptide level (including multiple occurrences), and a limited set of unique viral pentapeptides (1) .
In general, this large viral-versus-human peptide intersection indicates the possibility that a viral infection may cause a subversion of host cellular processes and immune responses. Indeed, once a viral infection has been established in the host, viral particles can multiply and, following proteolysis by cellular proteases, originate sets of viral peptides potentially able to enhance, inhibit or subvert host functions.
The ability of short viral fragments to alter a cellular process is exemplified by Epstein-Barr virus EBNA-1 Gly-Ala repeats (6, 7) . A chimeric protein in which an 8-mer fragment of the EBNA-1 Gly-Ala domain was inserted into the transcriptional repressor IkB, was ubiquitinated, but not degraded (8) . Eg, the Gly-Ala repeat prevented proteasomal proteolysis. This datum appears of special importance in light of the role exerted by IkB degradation in activating NF-kB, a pleiotropic transcriptional activator involved in cell growth, differentiation, tumorigenesis, apoptosis, inflammation, and immunity (9) .
Additional examples are the following: 1) HIV-1 peptides, such as naturally occurring variants HIV-1 p24 259-267 GDIYKRWII and p24 263-272 KRWIILGLNK, may prevent activation of specific T cells (10) .
2) The Nterminal LGASWHRPDKCCLGYQKRPLP peptide, aa 1-21, of the viral macrophage inflammatory protein-II encoded by Kaposi's sarcoma-associated human herpesvirus-8 DNA specifically binds CXCR4 chemokine receptor, with an important role in the binding exerted by the initial pentapeptide LGASW (11) . Knowing that CXCR4 may be used by HIV-1 to enter target cells (12) , the binding is important since might also lead to new therapeutic approaches for HIV infection. 3) CKS-17 is a 17 amino acids long (LQNRRGLDLLFLKEGG) immunosuppressive sequence which is present in many retroviral envelope proteins. Short synthetic peptides (LQNRRGLD and LDLLFL) derived from this sequence inhibit immune function in vitro and in vivo (13) (14) (15) . 4) Viral peptides have been found to trigger proliferative responses in diabetogenic BDC2.5 T-cells. Interestingly, MTAPSWARME, a peptide from the tegument protein of human herpes simplex virus type I, was the most active viral sequence at 1 microg/ml (16) .
In short, this representative sampling of data indicates that viral infections may produce viral fragments able to overlap/conflict/interfere with the physiological host cell functions, and supports the utilization of peptide matching as an observable phenetic attribute to define virus-host relationship. Aiming at identifying viral domains that might be linked to the JCV-associated pathogenic sequela in humans, the present study further explores the identity platform between JCV and Homo sapiens proteomes at the heptapeptide level and highlights a quantitative/qualitative picture of functional identities (eg, peptide motifs) that might be useful in evaluating the physio-pathological links between viruses and humans. As a note of special importance in regard to JCV-associated encephalopathies, the SGKTTLA peptide matching between the human nicotinamide/nicotinic acid riboside kinase 1 (NRK1) and JCV LT antigen is discussed.
METHODS
The analysed JCV amino acid (aa) primary sequence (Taxonomy ID: 10632; accession number: J02226; 5 proteins; length: 1,629 aa) is described at the URL http://www.uniprot.org/uniprot/?query=J02226&sort=score Abbreviations, UniProtKB/Swiss-Prot accession numbers, entry names, and length of the five viral proteins are as follows: large T antigen (LT ; P03072; LT_POVJC; 688aa); small T antigen (ST; P03083-1; ST_POVJC; 172aa); agnoprotein (Agno; P03086-1; AGNO_POVJC; 71aa); major capsid protein (VP1; P03089-1; VP1_POVJC; 354aa); minor capsid protein (VP2; P03095; VP2_POVJC; 344aa). The JCV polyprotein primary sequence was dissected into 1623 sequential heptamers that were analyzed for exact peptide matching to the human proteins using the Protein Information Resource (PIR) peptide match program (www.pir.georgetown.edu/pirwww/search/peptide.shtml) (17) . The viral 7-mer peptide sequences were offset by one residue each other, ie, sequentially overlapped by six residues. For each viral heptapeptide, the human proteome was searched for instances of the same 7-mer. The human proteins containing viral heptapeptide matches were analyzed utilizing UniProt database (http://www.uniprot.org) (18, 19). Table 1 lists the human proteins hosting JCV heptameric matches. Quantitatively, 53 viral heptapeptides are distributed among 64 human proteins. Qualitatively, an inspection of Table 1 indicates that JCV peptide motifs are located in human proteins that are component of the survival of motor neuron protein complex, catalyze cell adhesion, activate GTPase, (de)polymerize actin, and are involved in oligodendrocyte differentiation. Such proteins may potentially be associated, when altered, to spinal muscular atrophy, leukocyte adhesion-deficiency syndrome, T cell anergy, focal segmental glomerulosclerosis, oncogenesis, neuronal damages, axonal degeneration, and encephalopathies. The examples that follow give a brief survey of the cell subversion potential and possible pathologic correlates of the JCV-versushuman peptide overlap. Table 1 shows the following peptide sharing between the viral polyprotein and the human proteins involved in cell-to cell contacts:
RESULTS

Peptide sharing between JCV and human proteins involved in cell-cell adhesion/repulsion
The JCV LT/ST 46-52 GGDEDKM peptide sequence is shared with the human Rap1 GTPase-activating protein 1 (RGP2), a protein that is abundant in the cerebral cortex. RGP2 down-regulates the activity of Ras proximity 1 (Rap1). Dysregulations of the Rap1 signal in specific tissues result in certain disorders, including myeloproliferative disorders and leukemia, platelet dysfunction with defective hemostasis, leukocyte adhesiondeficiency syndrome, lupus-like systemic autoimmune disease, and T cell anergy (20) . Signaling via Rap1 transmits an inside-out signal to the integrins, thereby increasing adhesiveness to ligands such as immunoglobulin superfamily proteins as well as extracellular matrix proteins and plasma proteins. This process induces leukocyte cell adhesion to the endothelium and antigen-presenting cells (21) . Specifically, Rap1 promotes VEGFR2 activation and 1 UniProt/Swissprot accession numbers are given in bold. Human proteins were analyzed for functions and potential disease associations using Universal Protein Resource (see uniprot.org/uniprot and pertinent references therein) 2 Ag, viral antigens; abbreviations described under Methods. 3 Peptide sequences common to JCV LT and ST antigens angiogenesis by a mechanism involving integrin {alpha}v{beta}3 (22) .
The JCV VP1 295-301 SFLLTDL peptide belongs to leucine-rich repeat fibronectin type-III domain-containing protein 3 (LRFN3) also called synaptic adhesion-like molecule 4. It is strongly expressed in the adult brain and is also present in the adult gastrointestinal tract and kidneys. It is distributed throughout the neuron, including the growth cone. This molecule mediates homophilic cell-cell adhesion in a Ca2+-independent manner and promotes neurite outgrowth in hippocampal neurons (23) .
The JCV VP2 2-8 GAALALL sequence is present in human T-cell surface glycoprotein E2 (or CD99 antigen or protein MIC2). This molecule is involved in T-cell adhesion processes, and in spontaneous rosette formation with erythrocytes (24) .
JCV also shares a heptapeptide (EALELQG) with human semaphorin-4C (Sema4C), a repulsive molecule that negatively alters the movement of cells and their processes (25) . In particular, Sema-4C mutants display distinctive defects of the cerebellar granule cell layer, including gaps in rostral lobules, fusions of caudal lobules, and ectopic granule cells in the molecular layer (26) . Finally, Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney (27) . This last datum may represent a potential link between JCV infection and renal disease (28) .
An octapeptide (RTPRVDGQ) from JCV VP1 is also present in human MICAL2PV2 and MICAL2PV2, two flavoprotein oxidoreductases that function in plexin-mediated axonal repulsion (29) .
As repeatedly highlighted by scientific literature (30), adhesive and repellent molecules guide cell migration, modulate neurite growth, contribute to synaptic transmission and neuronal plasticity. Hence, the above described heptapeptide sharing involving the RGP2, LRFN3, CD99, Sema4C and MICALs proteins might interfere in essential steps of nervous system development.
Examples of peptide sharing between JCV and the neural network
The JCV LT/ST [14] [15] [16] [17] [18] [19] [20] MDLLGLD peptide sequence is present in the human stromal membraneassociated protein 2 (SMAP2), a GTPase activating protein that acts on ADP-ribosylation factor (ARF) 1, which, in turn, is involved in synaptic vesicle formation and has been implicated in mesial temporal lobe epilepsy, a sub-type of Epilepsy that disrupts inflammation processes, cell death, and synaptic reorganization in the hippocampus (31) .
The JCV LT 124-130 STPPKKK peptide sequence is found in the human zinc finger E-box binding homeobox 1 (ZEB1), a protein that inhibits interleukin-2 gene expression. In turn, interleukin-2 is thought to be important in lesion formation in acute disseminated encephalomyelitis (32) The JCV LT 128-134 KKKKKVE sequence is present in the human RE1-silencing transcription factor (REST), a transcriptional repressor which binds neuronrestrictive silencer element and represses neuronal gene transcription in non-neuronal cells. REST function is required for the differentiation of oligodendrocyte precursor cells into mature MBP-positive oligodendrocytes (33) .
The JCV LT 561-567 SEYLLEK sequence is present in Myosin IIIA and Myosin-IIIB, two actin-based motor with a protein kinase activity, plays a role in vision and hearing. And expressed in retina and retinal pigment epithelial cells (34).
JCV LT 429-437 IDSGKTTLA sequence and human EFG, FANCJ, and NRK1 proteins
The JCV LT aa 429-437 sequence is of special relevance in the present analysis since it hosts:
An octapeptide (IDSGKTTL) shared with the human elongation factor G, a mitochondrial GTPase that, when altered, leads to early fatal progressive hepatoencephalopathy (35, 36) . It is noteworthy to mention that the viral IDSGKTTL peptide constitutes the nucleotide binding site of the mitochondrial GTPase (http://www.uniprot.org/).
Three pentapeptide matches (namely DSGKT, KTTLA, and TTLAA) are in ATP-dependent RNA helicase BRIP1 protein or hFANCJ, a human protein associated to Fanconi anemia. The three pentapeptide matches assume relevance in the light of a report relating cerebroretinal vasculopathy and leukoencephalopathy and Fanconi's anemia-like phenotypes (37) A heptapeptide (SGKTTLA) occurring in the human nicotinamide/nicotinic acid riboside kinase 1 (NRK1), that may have a remarkable significance as a potential link between JCV infection and multiple sclerosis. Indeed, NRK1 is a key enzyme in the synthesis of nicotinamide adenine dinucleotide (NAD) (38) . Under conditions of NAD deficiency, neurons are susceptible to the degeneration characteristic of multiple sclerosis (39), and Kaneko et al. (40) have demonstrated that increased nicotinamide adenine dinucleotide levels protects axonal degeneration in experimental autoimmune encephalomyelitis models. Moreover, NAD is essential for the mammalian silent information regulator 2 (SIRT2), an NAD-dependent histone deacetylase with important roles in brain oligodendroglia, where it modulates the oligodendrocyte cytoskeleton during its differentiation and maturation (41) .
The substantial importance of the SGKTTLA heptapeptide matching is suggested by the fact that the viral SGKTTLA sequence is present in the NRK1 enzymatic region (42) , so that this viral-versus-human overlap may be critically involved in (and possibly alter) nicotinamide binding and/or catalysis (see Figure 1 ).
In essence, active JCV infection might cause a subversion of the functional NRK1 enzyme dynamics by binding and sequestering the NRK1 substrate(s) at level of LT SGKTTLA sequences. Such a de facto enzyme inactivation might lead to NAD shortage and depletion with the consequent neuronal damages as described above.
JCV VP2 295-302 MLPLLLGL sequence and human protein signal peptides
Of note, JCV motifs are also present in the Nterminal signal peptides of human proteins. Signal peptides govern protein transport and localization in the cell (44) . A viral-vrs-human overlap at level of signal sequences may cause a competition for signal peptide peptidases with consequent protein unprocessing and failure to reach the correct cellular localization. As a specific example, Table 1 shows that the JCV VP2 295-302 MLPLLLGL octapeptide is present in the signal peptide of human complement C1q tumor necrosis factor-related protein 4 precursor (C1QT4). This matching might cause a competition between viral and C1QT4 MLPLLLGL sequences for signal peptide peptidase and, eventually, determine unprocessing of human C1QT4 and failure to be secreted.
A part of the octamer MLPLLLGL, the heptapeptide LPLLLGL, is present in the signal peptide sequence of other crucial proteins such as a HLA class II histocompatibility antigen involved in freeing the peptide binding site for acquisition of antigenic peptides; and bone morphogenetic protein 1, that participates in dorsoventral patterning during early development by cleaving chordin.
Finally, a pentapeptide of the octamer MLPLLLGL (LPLLL) is present in the signal peptide of HtrA serine peptidase/protease 1 (HTRA1). Of note, defects in HTRA1 are associated to cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) (45) (46) (47) , characterized by homogeneously confluent white-matter changes and multiple lacunar infarctions in the basal ganglia and thalamus (48) .
In passing, it is of interest to note that viralvrs-human overlaps at level of signal sequences may be a harbinger of autoimmune reactions as signal peptides are broadly immunogenic (49). 
CONCLUSION
JCV infection may be associated to progressive multifocal leukoencephalopathy (PML). However, although PML was first described in 1958 as a complication of chronic lymphatic leukaemia and Hodgkin's disease (50), and JCV isolated from the brain of a patient with Hodgkin's disease in 1971 (51) , to date the pathogenesis of PML and the molecular link(s) to JCV remain unclear (52) . The present study shows that human proteins contain numerous JCV consensus sequences, sometimes allocated in critical sites and potentially able to interfere with crucial cellular functions. Among the examples discussed above, the sharing of SGKTTLA motif between the human NRK1 and JCV LT antigen (Figure 1 ) is of special significance since it might represent a direct link between active JCV infection and demyelinating leukoencephalopathies.
In sum, the present study is of note especially when considering the role exerted by short peptide modules in cell biology and immunology (53) . Indeed, proteinprotein interactions appear to occur at level of minimal modules; as a general rule, a pentapeptide is the minimal catalytic motif functionally involved in enzymic catalysis and immune recognition (54) (55) (56) (57) (58) . Also, pentameric motifs can mimic several of the effects of the full-length peptide/protein (59, 60) . Hence, the viral-versus-human heptapeptide described here offers a significant platform for investigating the still ill-defined physio-pathological network linking JCV and the human host.
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